These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 10500653

  • 1. Usefulness of the switch to tacrolimus in liver transplantation.
    González-Pinto I, Alonso O, Loinaz C, Gómez R, Rodríguez-Cañete A, Rodríguez F, Pérez-Saborido B, Paseiro G, Moreno-González E.
    Transplant Proc; 1999 Sep; 31(6):2425-6. PubMed ID: 10500653
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Tacrolimus (FK 506) therapy is associated with a significant reduction in immunosuppressive treatment failures following primary liver transplantation.
    Bechstein WO, Neuhaus P, McMaster P, Calne R, Pichlmayr R, Otto G, Williams R, Ericzon BG, Bismuth H.
    Transplant Proc; 1996 Apr; 28(2):1008-10. PubMed ID: 8623211
    [No Abstract] [Full Text] [Related]

  • 4. Long-term comparison of tacrolimus versus cyclosporine in liver transplantation. The US FK Study Group.
    Wiesner RH.
    Transplant Proc; 1998 Jun; 30(4):1399-400. PubMed ID: 9636565
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.
    Klintmalm GB, Goldstein R, Gonwa T, Wiesner RH, Krom RA, Shaw BW, Stratta R, Ascher NL, Roberts JW, Lake J.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):641-3. PubMed ID: 7679828
    [No Abstract] [Full Text] [Related]

  • 9. Canadian national retrospective chart review comparing the long term effect of cyclosporine vs. tacrolimus on clinical outcomes in patients with post-liver transplantation hepatitis C virus infection.
    Yoshida EM, Lilly LB, Marotta PJ, Mason AL, Bilodeau M, Vaillancourt M.
    Ann Hepatol; 2013 Feb; 12(2):282-93. PubMed ID: 23396740
    [Abstract] [Full Text] [Related]

  • 10. Tacrolimus in solid organ transplantation: an update.
    Shapiro R.
    Transplant Proc; 1999 Sep; 31(6):2203-5. PubMed ID: 10500545
    [No Abstract] [Full Text] [Related]

  • 11. Cyclosporine and tacrolimus (FK506): a comparison of efficacy and safety profiles.
    Henry ML.
    Clin Transplant; 1999 Jun; 13(3):209-20. PubMed ID: 10383101
    [Abstract] [Full Text] [Related]

  • 12. Tacrolimus (FK506) is superior to cyclosporine in liver transplantation.
    Busuttil RW, Holt CD.
    Transplant Proc; 1997 Jun; 29(1-2):534-8. PubMed ID: 9123119
    [No Abstract] [Full Text] [Related]

  • 13. Tacrolimus is superior to cyclosporine in liver transplantation.
    Busuttil RW, Holt CD.
    Transplant Proc; 1998 Aug; 30(5):2174-8. PubMed ID: 9723432
    [No Abstract] [Full Text] [Related]

  • 14. More effective immunosuppression with the use of FK506 after liver transplantation.
    Lo CM, Fan ST, Liu CL, Ng IO, Lam BK, Yong BH, Lai CL, Lau GK, Wong J.
    Transplant Proc; 2000 Nov; 32(7):2269-70. PubMed ID: 11120161
    [No Abstract] [Full Text] [Related]

  • 15. Optimization of the use of Calcineurin inhibitors in liver transplantation.
    de Mare-Bredemeijer EL, Metselaar HJ.
    Best Pract Res Clin Gastroenterol; 2012 Feb; 26(1):85-95. PubMed ID: 22482528
    [Abstract] [Full Text] [Related]

  • 16. Histopathological findings according to Banff-97 classification system comparing tacrolimus versus cyclosporine.
    Rodrigo E, Escallada R, Fernández-Fresnedo G, Ruiz JC, Piñera C, Herráez I, Cotorruelo JG, Zubimendi JA, de Francisco AL, Arias M.
    Transplant Proc; 2002 Aug; 34(5):1719-20. PubMed ID: 12176550
    [No Abstract] [Full Text] [Related]

  • 17. Neoral is superior to FK 506 in liver transplantation.
    Levy GA.
    Transplant Proc; 1998 Aug; 30(5):1812-5. PubMed ID: 9723293
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of cyclosporine A and FK506 with regard to complaints and psychosocial characteristics before and after liver transplantation.
    Scholler G, Rose M, Neuhaus R, Neuhaus P, Klapp BF.
    Transplant Proc; 1997 Aug; 29(5):2491-3. PubMed ID: 9270822
    [No Abstract] [Full Text] [Related]

  • 19. Conversion from cyclosporine to tacrolimus prevents transplant function loss due to acute steroid-resistant or chronic rejection in renal allograft recipients.
    Blume C, Hollenbeck M, Ivens K, Heering P, Hetzel GR, Grabensee B.
    Transplant Proc; 2001 Aug; 33(7-8):3161-3. PubMed ID: 11750357
    [No Abstract] [Full Text] [Related]

  • 20. Conversion to neoral provides effective rescue therapy for liver and kidney transplant patients intolerant of Prograf.
    Abouljoud M, Kumar MS, Brayman K, Emre S, Bynon SJ.
    Transplant Proc; 2001 Aug; 33(1-2):1027-8. PubMed ID: 11267175
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.